Athenex

-$0.27 (-5.93%) Today

-$0.20 (-4.67%) As of 11:16 AM UTC after-hours

Why Robinhood?

You can buy or sell Athenex and other stocks, options, and ETFs commission-free!

About ATNX

Athenex, Inc. Common Stock, also called Athenex, is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer.

CEO

Yiu Nam Lau

Employees

605

Headquarters

Buffalo, New York

Founded

2003

ATNX Key Statistics

Market Cap

339.47M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

24.37M

High Today

$4.77

Low Today

$3.95

Open Price

$4.77

Volume

12.08M

52 Week High

$15.24

52 Week Low

$3.66

ATNX News

Benzinga24h

Athenex: Q1 Earnings Insights

Shares of Athenex (NASDAQ:ATNX) moved higher by 2.2% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were do

BenzingaMay 5

Why Athenex's Stock Is Trading Higher Today

Athenex's (NASDAQ:ATNX) shares are trading higher after the company announced it acquired Kuur Therapeutics. Athenex stock is trading up 21.02% to a price of $

Analyst Ratings

44%

of 9 ratings

Buy

44.4%

Hold

55.6%

Sell

ATNX Earnings

-$0.53

-$0.41

-$0.29

-$0.17

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.40 per share

Actual

-$0.27 per share

Replay Earnings Call